Visitors Now:
Total Visits:
Total Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

InnovaDerma targets international expansion as it raises £540,000

Friday, November 25, 2016 1:09
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Beauty treatments developer InnovaDerma PLC (LON:IDP) is looking to kick on from its recent success in the US and has gone to the market to help fund more growth outside the UK.

Only last month, InnovaDerma confirmed that Skinny Tan had successfully entered the US markets, with several retailers opting to stock the self-tanning lotions.

The Australian firm is looking to strike while the iron is hot, and raised £540,000 through a placing of 771,000 new ordinary shares at 70p each to fund further growth into the European and US markets and enable it to meet the growing demand for its Skinny Tan self-tanning products.

“The funds raised put us in a strong position at a key stage of the company’s development as we seek to grow our business in the UK and the US and meet growing demand for Skinny Tan,” said chief executive Haris Chaudhry.

Currently, Skinny Tan is made in Australia but InnovaDerma announced last month that it would be bringing a “significant part” of the production process over to the UK to help improve the supply chain.

Production in the UK is scheduled to begin next month, InnovaDerma said.

Shares closed higher at 76.1p on Thursday.

Story by ProactiveInvestors

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.